Condition: STOMACH NEOPLASM · Gastric Cancer · Gastric Cancer Adenocarcinoma Metastatic · Sponsor: Asan Medical Center
To investigate efficacy and safety of lenvatinib in combination with nivolumab plus chemotherapy in gastric cancer patients with peritoneal metastasis and grade ≥ 2 ascites.
This description comes directly from the study's public registry record.
Hyung-Don Kim · 82-2-3010-0236 · kimhdmd@amc.seoul.kr
Jaewon Hyung · 82-2-3010-1464 · musicine123@gmail.com
Always discuss trial participation with your own doctor first.
| Asan Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07149090